ROGER D. DANSEY - 23 Sep 2021 Form 4 Insider Report for Seagen Inc.

Role
Chief Medical Officer
Signature
By: Jessica Nielsen Causey For: Roger Dansey
Issuer symbol
N/A
Transactions as of
23 Sep 2021
Net transactions value
+$595,400
Form type
4
Filing time
27 Sep 2021, 20:08:52 UTC
Previous filing
02 Sep 2021
Next filing
22 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Award $21,442 +129 +0.15% $166.22 85,468 23 Sep 2021 Direct F1, F2, F3
transaction SGEN Common Stock Award $573,958 +3,453 +4% $166.22 88,921 23 Sep 2021 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled in common stock upon vesting.
F2 The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 09/20/23, subject to continuous service with the Company until the vesting date.
F3 Number of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F4 The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 12/31/21, subject to continuous service with the Company until the vesting date.